Development and initial testing of the stroke rapid-treatment readiness tool

Dai Wai M. Olson; Margueritte Cox; Mark Constable; Gavin W. Britz; Cheryl B. Lin; Louise O. Zimmer; Gregg C. Fonarow; Lee H. Schwamm; Eric D. Peterson

doi:10.1097/JNN.0000000000000082

Development and initial testing of the stroke rapid-treatment readiness tool

Dai Wai M. Olson, Margueritte Cox, Mark Constable, Gavin W. Britz, Cheryl B. Lin, Louise O. Zimmer, Gregg C. Fonarow, Lee H. Schwamm, Eric D. Peterson

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.

Original language	English (US)
Pages (from-to)	267-273
Number of pages	7
Journal	Journal of Neuroscience Nursing
Volume	46
Issue number	5
DOIs	https://doi.org/10.1097/JNN.0000000000000082
State	Published - Oct 1 2014

Keywords

Acute stroke therapy
Intervention
Reperfusion
TPA
Therapy
Treatment

ASJC Scopus subject areas

Surgery
Endocrine and Autonomic Systems
Clinical Neurology
Medical–Surgical

Access to Document

10.1097/JNN.0000000000000082

Cite this

@article{c72a9149e98b4bacade35c4bc80a36e3,

title = "Development and initial testing of the stroke rapid-treatment readiness tool",

abstract = "No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the {"}Get With The Guidelines-Stroke{"} quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.",

keywords = "Acute stroke therapy, Intervention, Reperfusion, TPA, Therapy, Treatment",

author = "Olson, {Dai Wai M.} and Margueritte Cox and Mark Constable and Britz, {Gavin W.} and Lin, {Cheryl B.} and Zimmer, {Louise O.} and Fonarow, {Gregg C.} and Schwamm, {Lee H.} and Peterson, {Eric D.}",

note = "Publisher Copyright: Copyright {\textcopyright} 2014 American Association of Neuroscience Nurses.",

year = "2014",

month = oct,

day = "1",

doi = "10.1097/JNN.0000000000000082",

language = "English (US)",

volume = "46",

pages = "267--273",

journal = "Journal of Neuroscience Nursing",

issn = "0888-0395",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "5",

}

TY - JOUR

T1 - Development and initial testing of the stroke rapid-treatment readiness tool

AU - Olson, Dai Wai M.

AU - Cox, Margueritte

AU - Constable, Mark

AU - Britz, Gavin W.

AU - Lin, Cheryl B.

AU - Zimmer, Louise O.

AU - Fonarow, Gregg C.

AU - Schwamm, Lee H.

AU - Peterson, Eric D.

PY - 2014/10/1

Y1 - 2014/10/1

N2 - No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.

AB - No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.

KW - Acute stroke therapy

KW - Intervention

KW - Reperfusion

KW - TPA

KW - Therapy

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84925810877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925810877&partnerID=8YFLogxK

U2 - 10.1097/JNN.0000000000000082

DO - 10.1097/JNN.0000000000000082

M3 - Article

C2 - 25099063

AN - SCOPUS:84925810877

SN - 0888-0395

VL - 46

SP - 267

EP - 273

JO - Journal of Neuroscience Nursing

JF - Journal of Neuroscience Nursing

IS - 5

ER -

Development and initial testing of the stroke rapid-treatment readiness tool

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this